货号:A391735
同义名:
JRF 12; N,N'-Dibenzylquinazoline-2,4-diamine
DBeQ是一种选择性、强效、可逆的ATP竞争性p97抑制剂,IC50为1.5 μM。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | ATPase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (-)-Blebbistatin | 99%+ | ||||||||||||||||||
| PF 03716556 |
++++
H+/K+-ATPase, pIC50: ~6.5 |
99% | |||||||||||||||||
| Esomeprazole sodium | ✔ | 98% | |||||||||||||||||
| BTB06584 | ✔ | 99% | |||||||||||||||||
| Ciclopirox | ✔ | 97% | |||||||||||||||||
| CB-5083 |
++++
p97 AAA ATPase, IC50: 11 nM |
99%+ | |||||||||||||||||
| Ciclopirox olamine | ✔ | 99% | |||||||||||||||||
| Brefeldin A |
+++
ATPase (HCT 116), IC50: 0.2 μM |
99%+ | |||||||||||||||||
| Oligomycin A | ✔ | 99% | |||||||||||||||||
| Sodium orthovanadate |
+++
(Na,K)-ATPase, IC50: 40 nM |
25-28%V | |||||||||||||||||
| Golgicide A | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | P97 ATPase, which is also known as VCP (valosin-containing protein) or TERA (translational endoplasmic reticulum ATPase), has various substrates,such as LC3,HIF1A, CYP3a. It is involved in autophagy, ERAD pathway etc.. DBeQ can inhibit p97 selectively and potently in a reversible and ATP-competitive manner. Different from the conventional proteasome inhibitors, DBeQ affects both the UPS and autophagic protein degradation pathways. DBeQ can also rapidly activate caspases 3/7 and induce cell death, which target p97 in cancer therapy[1]. |
| 作用机制 | DBeQ binds to the active site of the D2 domain and inhibits p97 in an ATP-competition manner.[1] |
| Concentration | Treated Time | Description | References | |
| Escherichia coli DnaK | 100μM | Binds to DnaK without affecting its ATPase activity | J Biol Chem. 2021 Jan-Jun;296:100079. | |
| Escherichia coli ClpB | 45μM | Inhibits the ATPase activity of ClpB | J Biol Chem. 2021 Jan-Jun;296:100079. | |
| OVCAR8 | 3 μM | 48 h | To study the synergistic effect of DBeQ and Salubrinal on OVCAR8 cells, results showed that the combination enhances cytotoxicity. | Mol Oncol. 2016 Dec;10(10):1559-1574. |
| OVCAR5 | 4.5 ± 1.3 μM | 72 h | To evaluate the cytotoxic effect of DBeQ on OVCAR5 cells, results showed that DBeQ is cytotoxic to OVCAR5 cells. | Mol Oncol. 2016 Dec;10(10):1559-1574. |
| SKOV3 | 10 μM | 48 h | To study the apoptotic effect of DBeQ on SKOV3 cells, results showed that DBeQ induces apoptosis through caspase-3 activation. | Mol Oncol. 2016 Dec;10(10):1559-1574. |
| OVCAR10 | 2.5 ± 0.62 μM | 72 h | To evaluate the cytotoxic effect of DBeQ on ovarian cancer cell lines, results showed that DBeQ is cytotoxic to ovarian cancer cells. | Mol Oncol. 2016 Dec;10(10):1559-1574. |
| RPMI8226 cells | 10 μM | 48 h | Evaluate the inhibitory effect of DBeQ on cancer cell growth, observed significant growth inhibition | Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4834-9. |
| Hek293 cells | 10 μM | 2 h | Evaluate the effect of DBeQ on the ERAD pathway, observed accumulation of TCRα-GFP | Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4834-9. |
| HeLa cells | 10 μM | 3 h | Evaluate the effect of DBeQ on the autophagy pathway, observed accumulation of LC3-II | Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4834-9. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | LPS-induced lung damage model | Intraperitoneal injection | 20 mg/kg | Once daily for 7 days | DBeQ treatment significantly decreased the generation of p52 | J Biol Chem. 2015 Aug 7;290(32):19558-68 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.94mL 0.59mL 0.29mL |
14.69mL 2.94mL 1.47mL |
29.38mL 5.88mL 2.94mL |
|
| CAS号 | 177355-84-9 |
| 分子式 | C22H20N4 |
| 分子量 | 340.42 |
| SMILES Code | C1(NCC2=CC=CC=C2)=NC(NCC3=CC=CC=C3)=C4C=CC=CC4=N1 |
| MDL No. | MFCD03691820 |
| 别名 | JRF 12; N,N'-Dibenzylquinazoline-2,4-diamine |
| 运输 | 蓝冰 |
| InChI Key | QAIMUUJJAJBPCL-UHFFFAOYSA-N |
| Pubchem ID | 676352 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 35 mg/mL(102.81 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1